West Pharmaceutical Services, Inc. (WST)
West Pharma lifts 2026 profit forecast on strong demand for medical equipment
West Pharmaceutical on Thursday raised its annual profit and revenue forecasts after beating estimates for first-quarter results, betting on strong demand for its proprietary products that include syringes and cartridges for injectable drugs.
WST Likely to Beat Q1 Earnings Estimates: How to Play the Stock?
WST enters Q1 earnings with strong momentum, steady GLP-1 demand, and growth across high-value products, positioning it for another potential beat.
Reasons to Retain West Pharmaceutical Stock in Your Portfolio for Now
WST rides strong HVP demand and GLP-1 expansion, but tariffs, destocking pressures and European facility constraints pose near-term growth risks.
West Pharmaceutical Services (WST) Reports Next Week: Wall Street Expects Earnings Growth
West Pharmaceutical (WST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WST Expands Dublin Facility to Boost Injectable Therapy Capacity
West Pharmaceutical expands Dublin facility to boost injectable therapy capacity and strengthen its end-to-end manufacturing platform.
West Pharmaceutical Services, Inc. (WST) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript
West Pharmaceutical Services, Inc. (WST) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript
Cinctive Capital Management LP Makes New $3.76 Million Investment in West Pharmaceutical Services, Inc. $WST
Cinctive Capital Management LP bought a new stake in shares of West Pharmaceutical Services, Inc. (NYSE: WST) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 14,319 shares of the medical instruments supplier's stock, valued at approximately $3,756,000. Other institutional
Brown Brothers Harriman & Co. Has $64.89 Million Holdings in West Pharmaceutical Services, Inc. $WST
Brown Brothers Harriman and Co. lifted its holdings in West Pharmaceutical Services, Inc. (NYSE: WST) by 22.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 247,356 shares of the medical instruments supplier's stock after purchasing an
Reasons to Add West Pharmaceutical Stock to Your Portfolio Right Now
WST eyes growth from high-value components, GLP-1 drug demand and Annex 1 conversions, but generics destocking and European capacity constraints pose risks.
Why West Pharmaceutical Services (WST) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Wall Street Analysts Think West Pharmaceutical (WST) Could Surge 32.33%: Read This Before Placing a Bet
The mean of analysts' price targets for West Pharmaceutical (WST) points to a 32.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Why West Pharmaceutical Services (WST) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
